<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23192" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Hypernatremia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sonani</surname>
            <given-names>Bhavin</given-names>
          </name>
          <aff>HSHS St John's Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Naganathan</surname>
            <given-names>Srividya</given-names>
          </name>
          <aff>Jersey Shore University Medical center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Al-Dhahir</surname>
            <given-names>Mohammed A.</given-names>
          </name>
          <aff>Strong Memorial Hospital/ University of Rochester / visiting physician</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bhavin Sonani declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Srividya Naganathan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mohammed Al-Dhahir declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23192.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>The human body maintains sodium and water homeostasis by concentrating the urine secondary to the action of antidiuretic hormone (ADH) and increased fluid intake by a powerful thirst response. These mechanisms to protect against developing hypernatremia are impaired in certain vulnerable populations and conditions with vasopressin deficiency or unresponsiveness at the renal tubular level. Hypernatremia is defined as a serum sodium concentration of greater than 145 meq/l. This activity reviews the causes and presentation and highlights the role of the interprofessional team in its management</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the causes of hypernatremia.</p></list-item><list-item><p>Describe the evaluation of a patient with hypernatremia.</p></list-item><list-item><p>Summarize the treatment of hypernatremia.</p></list-item><list-item><p>Explain the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by hypernatremia.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23192&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23192">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-23192.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Sodium is a dominant cation in extracellular fluid&#x000a0;and is necessary for the maintenance of intravascular volume. The human body maintains sodium and water&#x000a0;homeostasis by concentrating the urine secondary to the action of antidiuretic hormone (ADH)&#x000a0;and increased fluid intake by a powerful thirst response. These mechanisms to protect against developing hypernatremia are impaired in certain vulnerable populations, vasopressin deficiency, or unresponsiveness at the renal tubular level. Hypernatremia is defined as a serum sodium concentration of greater than 145 meq/L.<xref ref-type="bibr" rid="article-23192.r1">[1]</xref><xref ref-type="bibr" rid="article-23192.r2">[2]</xref><xref ref-type="bibr" rid="article-23192.r3">[3]</xref><xref ref-type="bibr" rid="article-23192.r4">[4]</xref></p>
      </sec>
      <sec id="article-23192.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The basic mechanisms of hypernatremia are water deficit and excess solute. Total body water loss relative to solute loss is the most common reason for developing hypernatremia. Hypernatremia is usually associated with hypovolemia, which can occur in conditions that cause combined water and solute loss, where water loss is greater than sodium loss or free water loss. Combined loss can be seen in extra-renal conditions such as gastroenteritis, vomiting, prolonged nasogastric drainage,&#x000a0;burns, and excessive sweating. Excessive sweating can occur due to exercise, fever, or high heat exposure. Renal losses&#x000a0;can be seen in&#x000a0;intrinsic renal&#x000a0;disease, post-obstructive diuresis, and with the use of osmotic or loop diuretics. Hyperglycemia and mannitol are common causes of osmotic diuresis. Free water loss is seen with central or nephrogenic diabetes insipidus (DI) and also in conditions with increased insensible loss. Central DI can occur due to inadequate production of ADH. Common causes of central DI&#x000a0;are idiopathic, head trauma, cranial neoplasm, and pituitary infiltrative diseases, such as sarcoidosis and histiocytosis. Nephrogenic DI occurs due to tubular unresponsiveness to the action of ADH and can be inherited in an X-linked pattern or secondary to&#x000a0;certain medications, including lithium, foscarnet, and demeclocycline. Rarely, hypernatremia with inadequate fluid intake can be seen in breastfed babies, child or elder abuse, and patients with an impaired thirst response. Excess sodium&#x000a0;usually&#x000a0;is iatrogenic and seen in the hospital setting but&#x000a0;can be associated with improper formula mixing, excess sodium bicarbonate ingestion, salt tablet poisoning, hyperaldosteronism, and seawater drowning.<xref ref-type="bibr" rid="article-23192.r5">[5]</xref><xref ref-type="bibr" rid="article-23192.r6">[6]</xref><xref ref-type="bibr" rid="article-23192.r7">[7]</xref><xref ref-type="bibr" rid="article-23192.r8">[8]</xref></p>
      </sec>
      <sec id="article-23192.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Hypernatremia is primarily seen in infants and the elderly population. Infants receiving inadequate water replacement in the setting of gastroenteritis or ineffective breastfeeding are common scenarios. Premature&#x000a0;infants are at higher risk due to their relatively small mass to surface area and their dependency on the caretaker to administer fluids. Patients with neurologic impairment&#x000a0;also&#x000a0;are at risk due to impaired thirst mechanism and lack of water availability. Hypernatremia can occur in the hospital setting due to&#x000a0;hypertonic fluid&#x000a0;infusions, especially when combined with the patient's inability for adequate water&#x000a0;intake.<xref ref-type="bibr" rid="article-23192.r9">[9]</xref></p>
      </sec>
      <sec id="article-23192.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Sodium is important to maintain&#x000a0;extracellular fluid (ECF) volume. Changes in the ECF volume provide feedback to maintain total sodium content by increasing or decreasing sodium excretion in the urine. Sodium excretion also involves regulatory mechanisms such as the renin-angiotensin-aldosterone systems. When serum sodium increases, the plasma osmolality increases, which triggers the thirst response and ADH secretion, leading to renal water conservation and concentrated urine.<xref ref-type="bibr" rid="article-23192.r10">[10]</xref></p>
      </sec>
      <sec id="article-23192.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Most&#x000a0;patients present with symptoms&#x000a0;suggestive of fluid loss&#x000a0;and clinical signs of dehydration. Symptoms and signs of hypernatremia are secondary&#x000a0;to&#x000a0;central nervous system dysfunction and are seen when serum sodium rises rapidly or is greater than 160 meq/L. Infants and Children present with irritability and agitation, which can progress to lethargy, somnolence, and coma. Other symptoms include increased thirst response in alert patients and high-pitched cries in infants. Patients with diabetes insipidus&#x000a0;present with polyuria and polydipsia. The skin can feel doughy or velvety due to intracellular water loss. Orthostatic hypotension and tachycardia are usually present in hypovolemic hypernatremia. The patient&#x000a0;may have increased tone with brisk reflexes and myoclonus. It is important to remember that the degree of dehydration can be underestimated in children with hypernatremia due to a shift of water from the intracellular space to the extravascular space. Polyuria is one of the common symptoms of diabetes insipidus.<xref ref-type="bibr" rid="article-23192.r11">[11]</xref><xref ref-type="bibr" rid="article-23192.r12">[12]</xref></p>
      </sec>
      <sec id="article-23192.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The etiology of hypernatremia&#x000a0;usually&#x000a0;is evident based on history and physical examination. Plasma volume, plasma osmolality, urine volume, concentrating ability, and osmolality can help to further differentiate between renal and extrarenal causes. In DI, the urine is inappropriately diluted with normal urine volume and urine osmolality less than the serum osmolality. When DI is suspected, a water deprivation test may be performed with the administration of desmopressin. In central DI,&#x000a0;desmopressin&#x000a0;administration demonstrates an increase in urine osmolality, while in the nephrogenic variety, there is no response to desmopressin. In extrarenal causes, the body tries to conserve fluids with appropriately low urine volume, high specific gravity, and urine osmolality greater than serum osmolality.<xref ref-type="bibr" rid="article-23192.r13">[13]</xref></p>
      </sec>
      <sec id="article-23192.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Proper management of hypernatremia involves identifying the underlying condition and correcting the hypertonicity. The goal of therapy is to correct both the serum sodium and the intravascular volume. Fluids should be administered orally or via a&#x000a0;feeding tube whenever possible. In patients with severe dehydration or shock, the initial step is fluid resuscitation with isotonic fluids before free water correction. Hypernatremia is corrected by calculating the free water deficit using one of the following formulas.<xref ref-type="bibr" rid="article-23192.r14">[14]</xref><xref ref-type="bibr" rid="article-23192.r15">[15]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Total Body Water[0.6 in men and 0.5 in women x body weight(kg)] x [(plasma sodium/140) -1]</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>4ml x bodyweight x (desired change in serum sodium meq/L)</p>
          </list-item>
        </list>
        <p>It is important to remember that rapid correction of hypernatremia can lead to cerebral edema because water moves from the serum into the brain cells. The goal is to decrease serum sodium by not more than 12 meq in 24 hours. Close serial monitoring of serum sodium every 2 to 4 hours is essential during the acute phase of correction.&#x000a0;Seizures occurring during the correction of hypernatremia are a sign of cerebral edema due to rapid shifts in osmolality, and the administration of hypotonic fluids should be halted. The estimated free water deficit should be corrected over 48 to 72 hours with a decrease in serum sodium not exceeding 0.5 meq per hour. Patients should be carefully monitored for the rate of correction, urine output, and ongoing losses. In cases of sodium intoxication, the free water requirement may be too large and cause volume overload, requiring the use of loop diuretics and, at times, peritoneal dialysis to remove excess sodium. There are no published reports of seizures or cerebral edema complicating rapid correction of hypernatremia in adults. Older children and adults with central DI may need desmopressin, which is available in intranasal and oral forms. Water intoxication and hyponatremia are adverse effects seen with the use of desmopressin.</p>
      </sec>
      <sec id="article-23192.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Cirrhosis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Central diabetes insipidus</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Diarrhea</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hypocalcemia</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hyponatremia</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Nephrogenic diabetes insipidus</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Thirst defect</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Type 1 diabetes mellitus</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23192.s10" sec-type="Complications">
        <title>Complications</title>
        <p>The most serious complication of hypernatremia is subarachnoid or subdural hemorrhage due to the rupture of bridging veins and dural sinus thrombosis. It can lead to permanent brain damage or death. Rapid correction of chronic hypernatremia causes cerebral edema, seizure, and permanent brain damage.<xref ref-type="bibr" rid="article-23192.r16">[16]</xref></p>
      </sec>
      <sec id="article-23192.s11" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>Hypernatremia occurs due to net water loss or excess sodium intake.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>It is more common in infants or older populations with neurological or physical impairment.</p>
          </list-item>
          <list-item>
            <p>It is crucial to identify acute versus chronic onset hypernatremia before correcting the free water deficit.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>It is important to remember that hypernatremia should be corrected over 48 hours. Rapid correction can lead to cerebral edema and seizures.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23192.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Hypernatremia is best managed by an interprofessional team that includes an internist, endocrinologist, emergency department physician, nurse practitioner, and the primary care provider. The key is to identify the cause and correct the hypertonicity. The goal of therapy is to correct both the serum sodium and the intravascular volume. In patients with severe dehydration or shock, the initial step is fluid resuscitation with isotonic fluids before free water correction.</p>
        <p>Healthcare providers should be cognizant of the fact that rapid correction of hypernatremia can lead to cerebral edema because water moves from the serum into the brain cells. The goal is to decrease the serum sodium by not more than 10 to 12 meq/L in 24 hours. The acute phase of sodium correction requires monitoring of serum sodium levels every 2 to 4 hours. Frequent communication between the attending physician, the nursing staff, and the pharmacist is crucial to avoid the rapid correction of sodium levels. Rapid correction of sodium levels can lead to a seizure, cerebral edema, or permanent neurological deficit.&#x000a0;Special attention should be given to high-risk nursing home patients with neurological or physical impairments&#x000a0;who are prone to develop recurrent hypernatremia.&#x000a0;Discharge care coordination&#x000a0;among discharging physicians, primary care physicians, and nursing home staff can prevent readmission due to hypernatremia. Serum sodium and drug levels should be periodically monitored in patients who are taking medications known to cause nephrogenic diabetes insipidus.<xref ref-type="bibr" rid="article-23192.r17">[17]</xref><xref ref-type="bibr" rid="article-23192.r18">[18]</xref>&#x000a0;[Level 5]</p>
      </sec>
      <sec id="article-23192.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23192&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23192">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/hormones-and-body-chemistry/hypernatremia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=23192">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23192/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23192">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-23192.s14">
        <title>References</title>
        <ref id="article-23192.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barma</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Soiza</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Donnan</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>McGilchrist</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Frost</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Witham</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Serum sodium level variability as a prognosticator in older adults.</article-title>
            <source>Scand J Clin Lab Invest</source>
            <year>2018</year>
            <season>Nov-Dec</season>
            <volume>78</volume>
            <issue>7-8</issue>
            <fpage>632</fpage>
            <page-range>632-638</page-range>
            <pub-id pub-id-type="pmid">30755097</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23192.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Qian</surname>
                <given-names>Q</given-names>
              </name>
            </person-group>
            <article-title>Hypernatremia.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2019</year>
            <month>Mar</month>
            <day>07</day>
            <volume>14</volume>
            <issue>3</issue>
            <fpage>432</fpage>
            <page-range>432-434</page-range>
            <pub-id pub-id-type="pmid">30728169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23192.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Slaughter</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Watts</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vale</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Grieve</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Schep</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>The clinical toxicology of sodium hypochlorite.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2019</year>
            <month>May</month>
            <volume>57</volume>
            <issue>5</issue>
            <fpage>303</fpage>
            <page-range>303-311</page-range>
            <pub-id pub-id-type="pmid">30689457</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23192.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rubin</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Espiridion</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Kattan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Desmarais</surname>
                <given-names>EC</given-names>
              </name>
            </person-group>
            <article-title>Serotonin Syndrome with Atypical Hypernatremia.</article-title>
            <source>Cureus</source>
            <year>2018</year>
            <month>Nov</month>
            <day>19</day>
            <volume>10</volume>
            <issue>11</issue>
            <fpage>e3616</fpage>
            <pub-id pub-id-type="pmid">30680272</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23192.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yano</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Uchimura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nagahama</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yonaha</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Taniguchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tsuneyoshi</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Continuous hemodiafiltration for hypernatremia and a simple formula for stepwise regulation of the sodium concentration in a dialysate.</article-title>
            <source>J Clin Anesth</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>55</volume>
            <fpage>144</fpage>
            <page-range>144-145</page-range>
            <pub-id pub-id-type="pmid">30660092</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23192.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iraqi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Abilkassem</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dini</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Agadr</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>A three-year-old boy with hypodipsic hypernatremia syndrome.</article-title>
            <source>Pan Afr Med J</source>
            <year>2018</year>
            <volume>30</volume>
            <fpage>250</fpage>
            <pub-id pub-id-type="pmid">30627311</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23192.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Das</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Latif</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Islam</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Hossain</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Moniruzzaman</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Oliullah</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Haque</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Gosh</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Comparison of Serum Electrolytes Abnormality and Renal Function Status in Asphyxiated and Normal Baby in a Tertiary Level Hospital.</article-title>
            <source>Mymensingh Med J</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>723</fpage>
            <page-range>723-729</page-range>
            <pub-id pub-id-type="pmid">30487486</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23192.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Imai</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shibagaki</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>The prevalence of dysnatremia in the elderly patients without CKD.</article-title>
            <source>Am J Emerg Med</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>499</fpage>
            <page-range>499-501</page-range>
            <pub-id pub-id-type="pmid">30595426</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23192.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Braun</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Barstow</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Pyzocha</surname>
                <given-names>NJ</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of sodium disorders: hyponatremia and hypernatremia.</article-title>
            <source>Am Fam Physician</source>
            <year>2015</year>
            <month>Mar</month>
            <day>01</day>
            <volume>91</volume>
            <issue>5</issue>
            <fpage>299</fpage>
            <page-range>299-307</page-range>
            <pub-id pub-id-type="pmid">25822386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23192.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muhsin</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Mount</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and treatment of hypernatremia.</article-title>
            <source>Best Pract Res Clin Endocrinol Metab</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>189</fpage>
            <page-range>189-203</page-range>
            <pub-id pub-id-type="pmid">27156758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23192.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McManus</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Churchwell</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Strange</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Regulation of cell volume in health and disease.</article-title>
            <source>N Engl J Med</source>
            <year>1995</year>
            <month>Nov</month>
            <day>09</day>
            <volume>333</volume>
            <issue>19</issue>
            <fpage>1260</fpage>
            <page-range>1260-6</page-range>
            <pub-id pub-id-type="pmid">7566004</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23192.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adrogu&#x000e9;</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Madias</surname>
                <given-names>NE</given-names>
              </name>
            </person-group>
            <article-title>Hypernatremia.</article-title>
            <source>N Engl J Med</source>
            <year>2000</year>
            <month>May</month>
            <day>18</day>
            <volume>342</volume>
            <issue>20</issue>
            <fpage>1493</fpage>
            <page-range>1493-9</page-range>
            <pub-id pub-id-type="pmid">10816188</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23192.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nigro</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Grossmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chiang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Inder</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Polyuria-polydipsia syndrome: a diagnostic challenge.</article-title>
            <source>Intern Med J</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>48</volume>
            <issue>3</issue>
            <fpage>244</fpage>
            <page-range>244-253</page-range>
            <pub-id pub-id-type="pmid">28967192</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23192.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baldeweg</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Ball</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Brooke</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gleeson</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Prentice</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wass</surname>
                <given-names>J</given-names>
              </name>
              <collab>Society for Endocrinology Clinical Committee</collab>
            </person-group>
            <article-title>SOCIETY FOR ENDOCRINOLOGY CLINICAL GUIDANCE: Inpatient management of cranial diabetes insipidus.</article-title>
            <source>Endocr Connect</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>7</volume>
            <issue>7</issue>
            <fpage>G8</fpage>
            <page-range>G8-G11</page-range>
            <pub-id pub-id-type="pmid">29930026</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23192.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koch</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Fulop</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Clinical aspects of changes in water and sodium homeostasis in the elderly.</article-title>
            <source>Rev Endocr Metab Disord</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <page-range>49-66</page-range>
            <pub-id pub-id-type="pmid">28303369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23192.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>Hypernatemia : successful treatment.</article-title>
            <source>Electrolyte Blood Press</source>
            <year>2006</year>
            <month>Nov</month>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>66</fpage>
            <page-range>66-71</page-range>
            <pub-id pub-id-type="pmid">24459489</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23192.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoffman</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Verhave</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chin</surname>
                <given-names>LS</given-names>
              </name>
            </person-group>
            <article-title>Hypernatremia is associated with poorer outcomes following aneurysmal subarachnoid hemorrhage: a nationwide inpatient sample analysis.</article-title>
            <source>J Neurosurg Sci</source>
            <year>2021</year>
            <month>Oct</month>
            <volume>65</volume>
            <issue>5</issue>
            <fpage>486</fpage>
            <page-range>486-493</page-range>
            <pub-id pub-id-type="pmid">30514071</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23192.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramburuth</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moodley</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Gopalan</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>Preoperative serum sodium measurements and postoperative inpatient mortality: A case-control analysis of data from the South African Surgical Outcomes Study.</article-title>
            <source>S Afr Med J</source>
            <year>2018</year>
            <month>Oct</month>
            <day>02</day>
            <volume>108</volume>
            <issue>10</issue>
            <fpage>847</fpage>
            <page-range>847-851</page-range>
            <pub-id pub-id-type="pmid">30421713</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
